Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder

S. W. Hardeman, A. Perry, M. S. Soloway

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

From 1983 to 1986, 63 male patients received various regimens of intravesical therapy for superficial transitional cell carcinoma of the bladder. Of these 63 patients 10 were subsequently diagnosed as having transitional cell carcinoma of the prostate. Five of the 10 patients had no tumor remaining in the bladder at diagnosis of transitional cell carcinoma of the prostate. In 3 patients tumor in the prostate was more invasive than tumor in the bladder. In 2 patients tumor involvement was greater in the bladder than in the prostate. Patients undergoing treatment with intravesical therapy for transitional cell carcinoma of the bladder, especially those receiving multiple courses for prolonged periods, should be monitored closely for the development of transitional cell carcinoma of the prostate.

Original languageEnglish
Pages (from-to)289-292
Number of pages4
JournalJournal of Urology
Volume140
Issue number2
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Transitional Cell Carcinoma
Prostate
Urinary Bladder
Therapeutics
Neoplasms
Urinary Bladder Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder. / Hardeman, S. W.; Perry, A.; Soloway, M. S.

In: Journal of Urology, Vol. 140, No. 2, 01.01.1988, p. 289-292.

Research output: Contribution to journalArticle

@article{151336f6ea09424ea5939750808cd881,
title = "Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder",
abstract = "From 1983 to 1986, 63 male patients received various regimens of intravesical therapy for superficial transitional cell carcinoma of the bladder. Of these 63 patients 10 were subsequently diagnosed as having transitional cell carcinoma of the prostate. Five of the 10 patients had no tumor remaining in the bladder at diagnosis of transitional cell carcinoma of the prostate. In 3 patients tumor in the prostate was more invasive than tumor in the bladder. In 2 patients tumor involvement was greater in the bladder than in the prostate. Patients undergoing treatment with intravesical therapy for transitional cell carcinoma of the bladder, especially those receiving multiple courses for prolonged periods, should be monitored closely for the development of transitional cell carcinoma of the prostate.",
author = "Hardeman, {S. W.} and A. Perry and Soloway, {M. S.}",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "140",
pages = "289--292",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder

AU - Hardeman, S. W.

AU - Perry, A.

AU - Soloway, M. S.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - From 1983 to 1986, 63 male patients received various regimens of intravesical therapy for superficial transitional cell carcinoma of the bladder. Of these 63 patients 10 were subsequently diagnosed as having transitional cell carcinoma of the prostate. Five of the 10 patients had no tumor remaining in the bladder at diagnosis of transitional cell carcinoma of the prostate. In 3 patients tumor in the prostate was more invasive than tumor in the bladder. In 2 patients tumor involvement was greater in the bladder than in the prostate. Patients undergoing treatment with intravesical therapy for transitional cell carcinoma of the bladder, especially those receiving multiple courses for prolonged periods, should be monitored closely for the development of transitional cell carcinoma of the prostate.

AB - From 1983 to 1986, 63 male patients received various regimens of intravesical therapy for superficial transitional cell carcinoma of the bladder. Of these 63 patients 10 were subsequently diagnosed as having transitional cell carcinoma of the prostate. Five of the 10 patients had no tumor remaining in the bladder at diagnosis of transitional cell carcinoma of the prostate. In 3 patients tumor in the prostate was more invasive than tumor in the bladder. In 2 patients tumor involvement was greater in the bladder than in the prostate. Patients undergoing treatment with intravesical therapy for transitional cell carcinoma of the bladder, especially those receiving multiple courses for prolonged periods, should be monitored closely for the development of transitional cell carcinoma of the prostate.

UR - http://www.scopus.com/inward/record.url?scp=0023713248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023713248&partnerID=8YFLogxK

M3 - Article

C2 - 3135420

AN - SCOPUS:0023713248

VL - 140

SP - 289

EP - 292

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -